Kinesins and Cancer

<p>Preface     <br>                                                                                                             1 The kinesin superfamily<br>Kristen J. Verhey, Jared C. Cochran and Claire E. Walczak                        <br> <br>2 The discovery and development of Eg5 inhibitors for the clinic<br>James A.D. Good, G. Berretta, Nahoum G. Anthony and Simon P.Mackay                                                                                                     </p><p><p>3 Mechanism of action of Eg5 inhibitors<br>Robert A.Cross                                                                                                        </p><p><p>4 Clinical trials of mitotic kinesin inhibitors<br>Steven S.Rosenfeld                                                                                                  </p><p><p>5 Kif15; a useful target for anti-cancer therapy?<br>Roy G.H.P. van Heesbeen and Rene H.Medema  </p><p> 6 Down-regulating CENP-E activity: for better or for worse<br>Julien Espeut and ArianeAbrieu<br></p><p>7  The human kinesin-14 motor KifC1/HSET is an attractive anti-cancer drug target<br>Vaishali Pannu, Padmashree C.G. Rida and Ritu Aneja                                        <br><br>8  Kinesin-13 Microtubule Depolymerizing Proteins as targets for cancer therapy<br>Anutosh Ganguly and Fernando  Cabral                                                                    <br><br>9 Chromokinesins in genome maintenance and cancer<br>Manjari Mazumdar and Tom Misteli                                                                        <br><br>10 Kif14: a clinically relevent kineisn and potential target for cancer therapy<br>Brigitte L. Theriault and Timothy W. Corson                                                           <br><br>11 Kinesin-8 members and their potnetial as biomarker or therapeutic target<br>Thomas U. Mayer and Silke Hauf                                                                            <br><br>12 The kinesin-6 members MKLP1, MKLP2 and MPP1<br>Ryan D. Baron and Francis Barr                                                                             <br><br>13  Non-motor spindle proteins as cancer chemotherapy targets<br>Bob Margolis and Mythili Yenjerla                                                                           <br><br>14  Inhibitors of mitotic kinesins for cancer treatment: consequences for neurons<br>Olga I. Kahn and Peter Baas                                                                                                Index                                                                                                                           </p><p>            </p><p>            </p>